The level of deletion 17p and bi-allelic inactivation of <i>TP53</i> has a significant impact on clinical outcome in multiple myeloma
2017 · Haematologica · 78 citations
https://doi.org/10.3324/haematol.2017.168872
D
Daisy Alapat
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
1.7K
Citations
18
h-index
24
i10-index
Daisy Alapat is an academic researcher from University of Arkansas for Medical Sciences. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Lymphoma Diagnosis and Treatment & Protein Degradation and Inhibitors. The author has an h-index of 18, co-authored 91 publications.
ORCID: 0000-0002-3414-8375Papers by this author
worksDose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma
2016 · Blood Cancer Journal · 34 citations
https://doi.org/10.1038/bcj.2016.64
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages
2024 · Blood Cancer Journal · 24 citations
https://doi.org/10.1038/s41408-024-01172-x
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma
2023 · Cell Reports Medicine · 17 citations
https://doi.org/10.1016/j.xcrm.2023.101214
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat